This study demonstrated that during ALS disease progression, CCR2 expression expanded from CNS-infiltrating monocytes to centrally resident microglia and neurons, resulting in the toxic transformation of microglia and neurons, leading to accelerated ALS pathology. The gene discussed is CCR2; the disease is amyotrophic lateral sclerosis.